POST-FEDERAL BUDGET RESPONSE: AUSTRALIAN THYROID FOUNDATION 1 million Australians with undiagnosed thyroid disorders remain at risk of irreparable damage
At the Post Budget Breakfast hosted by AIPS and Medicines Australia, the Honourable Mark Butler MP, Minister for Health and Aged Care spoke about the health priorities of the Federal Budget 2024-25.
As with all Federal Budgets, there is a submission process to lodge requests by January of each year. For the Federal Budget this year, there were 788 submissions lodged, one of which was by the Australian Thyroid Foundation (ATF).
The ATF is a national not-for-profit organisation with charity status aimed at patients and the healthcare community. The ATF’s focus is to support and educate its member base and promote our Good Thyroid Health Messaging throughout the Australian Community.
Australian Thyroid Foundation, CEO Beverley Garside attending the breakfast gave her response to the Federal Budget and the Foundation’s pre-budget submission, which was not granted.
The 3 requests for funding were for,
1. Education tool kit for health care professionals, to use during patient presentations
2. Broad media campaign aimed at young families moving away from standard dietary choices and awareness about the importance of iodine and thyroid health
3. Dietary book for senior Australians with an iodine slant to improve health outcomes, with healthy living choices.
According to the Australia Thyroid Foundation, over 1 million Australians are living with an undiagnosed thyroid disorder. These disorders can affect children, pregnant women, families and the elderly.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
Belonging in a medical device company
Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
-
Being Part of the New Health Frontier
In November last year, the House of Representatives Standing Committee on Health, Aged Care and Sport delivered its bipartisan report “The New Frontier: Delivering better health for all Australians” on the approval processes for new drugs and novel medical technologies in Australia.
Australian Health Journal spoke to some of the industry bodies who were part of the Inquiry, for their comments on the process, the report and hopes in the recommendations being implemented.
